Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Clarus Ventures I GP, L.P. — AVANIR PHARMACEUTICALS insider: 1 transactions · InsiderLens

Home / Insiders / Clarus Ventures I GP, L.P.

Clarus Ventures I GP, L.P.

10% owner at AVANIR PHARMACEUTICALS · on record since Apr 11, 2008

Insider trading activity of Clarus Ventures I GP, L.P.

Transactions on record: 1; since Dec 7, 2010

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Dec 7, 2010

Figures computed from official regulatory filings — methodology.

Companies where Clarus Ventures I GP, L.P. has traded

AVANIR PHARMACEUTICALS1 tx · Dec 7, 2010

Track record of Clarus Ventures I GP, L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Clarus Ventures I GP, L.P.

Co-insiders of Clarus Ventures I GP, L.P.

AUSTIN STEPHEN GAVANIR PHARMACEUTICALS
BERG JAMES EAVANIR PHARMACEUTICALS
Bishop Hans EdgarAVANIR PHARMACEUTICALS
BRANDT ERICAVANIR PHARMACEUTICALS
CARLO DENNIS J PHDAVANIR PHARMACEUTICALS
Clarus Lifesciences I, L.P.AVANIR PHARMACEUTICALS
Clarus Ventures I, LLCAVANIR PHARMACEUTICALS

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

CORRIGAN MARKAVANIR PHARMACEUTICALS

EMANUELE ROBERT MARTINAVANIR PHARMACEUTICALS

FERNANDEZ GUSAVANIR PHARMACEUTICALS

GALAKATOS NICHOLASAVANIR PHARMACEUTICALS

GEORGE MICHAEL WAVANIR PHARMACEUTICALS

GLAVIN JAMES BAVANIR PHARMACEUTICALS

GOLDING SUSANAVANIR PHARMACEUTICALS

HANSEN JOHN DAVIDAVANIR PHARMACEUTICALS

HANSON GREGORY PAVANIR PHARMACEUTICALS

HENNER DENNISAVANIR PHARMACEUTICALS

HOPEREESE THERESAAVANIR PHARMACEUTICALS

ISALY SAMUEL DAVANIR PHARMACEUTICALS

Katkin KeithAVANIR PHARMACEUTICALS

Kaye RandallAVANIR PHARMACEUTICALS

LIPTAK ROBERTAVANIR PHARMACEUTICALS

LYLE CORINNE HAVANIR PHARMACEUTICALS

MATHEWS CHARLESAVANIR PHARMACEUTICALS

Mazzo David JAVANIR PHARMACEUTICALS

Moorin JayAVANIR PHARMACEUTICALS

OBERKFELL HAROLD FAVANIR PHARMACEUTICALS

OCAMPO CHRISTINEAVANIR PHARMACEUTICALS

OLSON KENNETH EAVANIR PHARMACEUTICALS

ORBIMED ADVISORS LLCAVANIR PHARMACEUTICALS

ORBIMED CAPITAL II LLCAVANIR PHARMACEUTICALS

PALEKAR ROHANAVANIR PHARMACEUTICALS

Podlesak DennisAVANIR PHARMACEUTICALS

PUNTORIERO MICHAEL JAVANIR PHARMACEUTICALS

SCHREIBER ALAINAVANIR PHARMACEUTICALS

Sibold William JohnAVANIR PHARMACEUTICALS

Siffert Joao MDAVANIR PHARMACEUTICALS

SILVERSTEIN JONATHANAVANIR PHARMACEUTICALS

Simon NicholasAVANIR PHARMACEUTICALS

SIRCAR JAGADISH CAVANIR PHARMACEUTICALS

SMITH VICTORIAAVANIR PHARMACEUTICALS

STEINMETZ MICHAELAVANIR PHARMACEUTICALS

Sturgeon Martin JAVANIR PHARMACEUTICALS

THOMAS PAULAVANIR PHARMACEUTICALS

Vivo Ventures Fund VI, L.P.AVANIR PHARMACEUTICALS

Vivo Ventures VI, LLCAVANIR PHARMACEUTICALS

WHEELER CRAIG AAVANIR PHARMACEUTICALS

WHEELER KURTAVANIR PHARMACEUTICALS

Whitcup Scott MAVANIR PHARMACEUTICALS

YAKATAN GERALD J PHDAVANIR PHARMACEUTICALS

Company	Filed	Type	Qty	Price	Value · USD	Src
AVANIR PHARMACEUTICALS	Dec 7, 2010	Other	-6,669,204	0.00 USD	$0	SEC